[HTML][HTML] Heads or tails? Choosing a salvage therapy for relapsed/refractory Hodgkin lymphoma

AP Skarbnik, B Pro - Expert Review of Hematology, 2013 - Taylor & Francis
Within the past decade, newer salvage combination chemotherapy regimens have been
studied for relapsed or refractory HL, and have been shown to induce significant responses …

[引用][C] Heads or tails? Choosing a salvage therapy for relapsed/refractory Hodgkin lymphoma.

AP Skarbnik, B Pro - Expert Review of Hematology, 2013 - europepmc.org
Heads or tails? Choosing a salvage therapy for relapsed/refractory Hodgkin lymphoma. -
Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About …

Heads or tails? Choosing a salvage therapy for relapsed/refractory Hodgkin lymphoma

AP Skarbnik, B Pro - Expert Review of Hematology, 2013 - go.gale.com
Hodgkin lymphoma (HL) is an uncommon malignancy, accounting for approximately 11% of
all malignant lymphomas. It is estimated that in 2012, there will be 9060 new HL diagnoses …

[引用][C] Heads or tails? Choosing a salvage therapy for relapsed/refractory Hodgkin lymphoma

AP Skarbnik, B Pro - Expert review of hematology, 2013 - pubmed.ncbi.nlm.nih.gov

[引用][C] Heads or tails? Choosing a salvage therapy for relapsed/refractory Hodgkin lymphoma

AP Skarbnik, B Pro - Expert Review of Hematology, 2013 - scholars.northwestern.edu
Heads or tails? Choosing a salvage therapy for relapsed/refractory Hodgkin lymphoma —
Northwestern Scholars Skip to main navigation Skip to search Skip to main content Northwestern …

Heads or tails? Choosing a salvage therapy for relapsed/refractory Hodgkin lymphoma

AP Skarbnik, B Pro - Expert Review of Hematology, 2013 - search.proquest.com
Within the past decade, newer salvage combination chemotherapy regimens have been
studied for relapsed or refractory HL, and have been shown to induce significant responses …